a phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion第一阶段试验的药物之间的相互作用皮肤和司立吉林4可卡因输液.pdfVIP

BMC Clinical Pharmacology BioMed Central Research article Open Access A Phase 1 Trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion 1,2 3 3 4 Debra S Harris* , Thomas Everhart , Peyton Jacob III , Emil Lin , 5 3 John E Mendelson and Reese T Jones Address: 1Department of Psychiatry, University of Cincinnati, OH, USA, 2Cincinnati VA Medical Center, OH 45220, USA, 3Drug Dependence Research Center, University of California, San Francisco, USA, 4Drug Studies Unit, University of California, San Francisco, USA and 5Addiction Pharmacology Research Laboratory, California Pacific Medical Center Research Institute, San Francisco, CA, USA Email: Debra S Harris* - debra.harris4@; Thomas Everhart - edwin.everhart@; Peyton Jacob - peyton.jacob@; Emil Lin - emil.lin@; John E Mendelson - john.mendelson@; Reese T Jones - reese.jones@ * Corresponding author Published: 1 August 2009 Received: 12 June 2009 Accepted: 1 August 2009 BMC Clinical Pharmacology 2009, 9:13 doi:10.1186/1472-6904-9-13 This article is available from: /1472-6904/9/13 © 2009 Harris et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background